ARTICLE SUMMARY:
With sensors that measure the response of nerves to stimulation and algorithms that adjust each pulse of a neurostimulation device to keep it in a therapeutic range, Saluda Medical sees early signs that it can boost the efficacy of spinal cord stimulation for pain and other neuromodulation therapies.
Medical device companies see a significant business opportunity for spinal cord stimulation: 100 million people in the US alone live with chronic pain, and clinicians looking to avoid prescribing opioids for their patients want to turn to a safe and efficacious alternative to drugs.
